Germline and somatic imprinting in the nonhuman primate highlights species differences in oocyte methylation
Rattachement africain : sg, gb. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Genomic imprinting is an epigenetic mechanism resulting in parental allele-specific gene expression. Defects in normal imprinting are found in cancer, assisted reproductive technologies, and several human syndromes. In mouse models, germline-derived DNA methylation is shown to regulate imprinting. Though imprinting is largely conserved between mammals, species- and tissue-specific domains of imprinted expression exist. Using the cynomolgus macaque (Macaca fascicularis) to assess primate-specific imprinting, we present a comprehensive view of tissue-specific imprinted expression and DNA methylation at established imprinted gene clusters. For example, like mouse and unlike human, macaque IGF2R is consistently imprinted, and the PLAGL1, INPP5F transcript variant 2, and PEG3 imprinting control regions are not methylated in the macaque germline but acquire this post-fertilization. Methylome data from human early embryos appear to support this finding. These suggest fundamental differences in imprinting control mechanisms between primate species and rodents at some imprinted domains, with implications for our understanding of the epigenetic programming process in humans and its influence on disease.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Germline and somatic imprinting in the nonhuman primate highlights species differences in oocyte methylation
- Date Crossref
- 10/04/2015
- Éditeur
- Cold Spring Harbor Laboratory
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Agency for Science pays non établi dans la noticeOrganisme public
-
Singapore Institute for Clinical Sciences Development and Metabolism Program pays non établi dans la noticeStructure de recherche
-
University of Cambridge Singapore Institute for Clinical Sciences pays non établi dans la noticeUniversité ou école supérieure
Agency for Science, Development and Metabolism Program — Singapore Institute for Clinical Sciences et Singapore Institute for Clinical Sciences — University of Cambridge.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.